These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 28339387

  • 1. Introduction to Quality Control in a Compounding Pharmacy.
    Allen LV.
    Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
    [Abstract] [Full Text] [Related]

  • 2. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV.
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [Abstract] [Full Text] [Related]

  • 3. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
    Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
    [No Abstract] [Full Text] [Related]

  • 4. The "Lists": What Do They Mean?
    Voliva J.
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Compounding pharmacies: before and after an inspection.
    Kulkarni D, Ricketts S.
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [Abstract] [Full Text] [Related]

  • 7. Quality Control: Photodocumentation in Pharmacy Compounding.
    Allen LV.
    Int J Pharm Compd; 2022; 26(2):116-117. PubMed ID: 35413010
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quality Assurance and Quality Control, Part 2.
    Akers MJ.
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [Abstract] [Full Text] [Related]

  • 11. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P, Pantano D, Gennari CG, Casiraghi A.
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [Abstract] [Full Text] [Related]

  • 12. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES.
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [Abstract] [Full Text] [Related]

  • 13. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
    Pritchett J, McCrory G, Kraemer C, Jensen B, Allen LV.
    Int J Pharm Compd; 2018 Mar; 22(1):7-16. PubMed ID: 29385381
    [Abstract] [Full Text] [Related]

  • 14. Drug product quality.
    Exp Med Surg; 1971 Mar; 29(1):135-44. PubMed ID: 5147595
    [No Abstract] [Full Text] [Related]

  • 15. [Improving the quality of compounded medicines through self-assessment: proof of concept].
    Wauters K, Fierens C, Corthout J, Sarre S, Saevels J.
    J Pharm Belg; 2014 Jun; (2):26-33. PubMed ID: 25055453
    [Abstract] [Full Text] [Related]

  • 16. Traditional vs. nontraditional pharmacy.
    Allen LV.
    Int J Pharm Compd; 2013 Jun; 17(4):351. PubMed ID: 24261152
    [No Abstract] [Full Text] [Related]

  • 17. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
    de Wilde S, de Jong MGH, Le Brun PPH, Guchelaar HJ, Schimmel KJM.
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
    [Abstract] [Full Text] [Related]

  • 18. Compounding pharmacies: who is in charge?
    Pergolizzi JV, Labhsetwar S, LeQuang JA.
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [Abstract] [Full Text] [Related]

  • 19. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K.
    Am J Health Syst Pharm; 2013 Feb 01; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract] [Full Text] [Related]

  • 20. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D.
    Int J Pharm Compd; 2017 Feb 01; 21(2):95-102. PubMed ID: 28346203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.